---
document_datetime: 2023-09-21 18:28:53
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/maci-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: maci-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 2.0310697
conversion_datetime: 2025-12-17 08:10:27.133389
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
<!-- image -->

<!-- image -->

| Application number   | Scope                                                                                                               | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on no   | Product Information affected 3   | Summary                           |
|----------------------|---------------------------------------------------------------------------------------------------------------------|-------------------------------------|------------------------------------------------|----------------------------------|-----------------------------------|
| PSUSA/10116 /201506  | Periodic Safety Update EU Single assessment - MATRIX APPLIED CHARACTERISED AUTOLOGOUS CULTURED CHONDROCYTES product | 14/01/2016                          | n/a                                            |                                  | PRAC Recommendation - maintenance |
| IAIN/0009            | A.1 - Administrative change - Change in the name and/or address of the MAH                                          | 17/09/2015                          |                                                | SmPC, Labelling and PL           |                                   |
| PSUSA/10116          | Periodic Safety Update EU Single assessment -                                                                       | 09/07/2015                          | n/a                                            |                                  | PRAC Recommendation - maintenance |

<!-- image -->

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5520 Send a question via our website www.ema.europa.eu/contact MACI Procedural steps taken and scientific information after the authorisation 1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures. 2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). edicinal product no longer authorised

<div style=\"page-break-after: always\"></div>

| /201412   | MATRIX APPLIED CHARACTERISED AUTOLOGOUS CULTURED CHONDROCYTES                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |            |               |                                                                                |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|---------------|--------------------------------------------------------------------------------|
| IAIN/0008 | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 06/07/2015 | n/a           |                                                                                |
| IAIN/0006 | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 10/03/2015 | n/a           | longer                                                                         |
| PSUV/0005 | Periodic Safety Update                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 09/01/2015 | n/a           | PRAC Recommendation - maintenance                                              |
| A20/0004  | On 8 September 2014, the MAH notified the European Medicines Agency of the withdrawal by the Danish authorities of the manufacturing licence for the manufacturing site for the active substance, finished product and batch release of MACI (matrix-applied characterised autologous cultured chondrocytes). The European Commission therefore initiated a procedure under Article 20 of Regulation (EC) No 726/2004 on 10 September 2014, requesting the Agency to give its opinion on whether the marketing authorisation for MACI should be suspended or revoked in accordance with Article 118 of Directive 2001/83/EC. product | 25/09/2014 | 19/11/2014 no | Please refer to the CHMP assessment report: MACI EMEA/H/A20/1409/C/002522/0004 |
| PSUV/0002 | Periodic Safety Update                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 11/09/2014 | n/a           | PRAC Recommendation - maintenance                                              |

edicinal product no longer authorised

<div style=\"page-break-after: always\"></div>

| T/0003   | Transfer of Marketing Authorisation                                                                                                                             | 13/08/2014   | 26/08/2014   | SmPC, Labelling and PL   |
|----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|--------------------------|
| IG/0418  | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location | 11/04/2014   | n/a          |                          |

edicinal product no longer authorised